Zandee van Rilland Eddy D, Yoon Se-Young, Garner Hillary W, Ni Mhuircheartaigh Jennifer, Wu Jim S
Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Sherman 231, Boston, MA, 02215, USA.
Department of Radiology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.
Eur Radiol. 2024 Oct;34(10):6581-6589. doi: 10.1007/s00330-024-10687-7. Epub 2024 Mar 15.
To determine if macroscopic intralesional fat detected in bone lesions on CT by Hounsfield unit (HU) measurement and on MRI by macroscopic assessment excludes malignancy.
All consecutive CT-guided core needle biopsies (CNB) of non-spinal bone lesions performed at a tertiary center between December 2005 and September 2021 were reviewed. Demographic and histopathology data were recorded. All cases with malignant histopathology were selected, and imaging studies were reviewed. Two independent readers performed CT HU measurements on all bone lesions using a circular region of interest (ROI) to quantitate intralesional fat density (mean HU < -30). MRI images were reviewed to qualitatively assess for macroscopic intralesional fat signal in a subset of patients. Inter-reader agreement was assessed with Cronbach's alpha and intraclass correlation coefficient.
In 613 patients (mean age 62.9 years (range 19-95 years), 47.6% female), CT scans from the CNB of 613 malignant bone lesions were reviewed, and 212 cases had additional MRI images. Only 3 cases (0.5%) demonstrated macroscopic intralesional fat on either CT or MRI. One case demonstrated macroscopic intralesional fat density on CT in a case of metastatic prostate cancer. Two cases demonstrated macroscopic intralesional fat signal on MRI in cases of chondrosarcoma and osteosarcoma. Inter-reader agreement was excellent (Cronbach's alpha, 0.95-0.98; intraclass correlation coefficient, 0.90-0.97).
Malignant lesions rarely contain macroscopic intralesional fat on CT or MRI. While CT is effective in detecting macroscopic intralesional fat in primarily lytic lesions, MRI may be better for the assessment of heterogenous and infiltrative lesions with mixed lytic and sclerotic components.
Macroscopic intralesional fat is rarely seen in malignant bone tumors and its presence can help to guide the diagnostic workup of bone lesions.
• Presence of macroscopic intralesional fat in bone lesions has been widely theorized as a sign of benignity, but there is limited supporting evidence in the literature. • CT and MRI are effective in evaluating for macroscopic intralesional fat in malignant bone lesions with excellent inter-reader agreement. • Macroscopic intralesional fat is rarely seen in malignant bone lesions.
通过 CT 测量的 Hounsfield 单位(HU)和 MRI 上的宏观评估来确定骨病变中检测到的宏观瘤内脂肪是否排除恶性肿瘤。
回顾了 2005 年 12 月至 2021 年 9 月在一家三级中心进行的所有连续的非脊柱骨病变 CT 引导下核心针活检(CNB)。记录了人口统计学和组织病理学数据。选择所有恶性组织病理学的病例,并对影像学研究进行了回顾。两名独立的读者对所有骨病变进行 CT HU 测量,使用圆形感兴趣区域(ROI)来定量评估瘤内脂肪密度(平均 HU<-30)。对部分患者的 MRI 图像进行了宏观瘤内脂肪信号的定性评估。采用 Cronbach's alpha 和组内相关系数评估读者间的一致性。
在 613 名患者(平均年龄 62.9 岁(范围 19-95 岁),47.6%为女性)中,回顾了 613 例恶性骨病变的 CNB CT 扫描,其中 212 例有额外的 MRI 图像。只有 3 例(0.5%)在 CT 或 MRI 上表现出宏观瘤内脂肪。1 例转移性前列腺癌患者 CT 上表现出宏观瘤内脂肪密度。2 例软骨肉瘤和骨肉瘤患者 MRI 上表现出宏观瘤内脂肪信号。读者间的一致性非常好(Cronbach's alpha,0.95-0.98;组内相关系数,0.90-0.97)。
恶性病变在 CT 或 MRI 上很少有宏观瘤内脂肪。虽然 CT 能有效地检测主要溶骨性病变中的宏观瘤内脂肪,但 MRI 可能更适合评估混合溶骨性和硬化性成分的异质性和浸润性病变。
恶性骨肿瘤中很少见到宏观瘤内脂肪,其存在有助于指导骨病变的诊断评估。
骨病变中存在宏观瘤内脂肪已被广泛认为是良性的标志,但文献中支持这一观点的证据有限。
CT 和 MRI 能有效评估恶性骨病变中的宏观瘤内脂肪,读者间的一致性非常好。
恶性骨病变中很少见到宏观瘤内脂肪。